Indian Kanoon - Search engine for Indian Law

7. In this context, all the petitioners have stated that they issued the revised price list to all their distributors and retailers, as required under the new notifications. The learned counsel also state that all the manufacturers have done whatever they could do to ensure that the formulations are sold at the revised prices or the prices marked on the containers, whichever are lower.

8. It has also been brought to our notice that in most of the writ petitions, demand notices have been sent by the Director NPPA (National Pharmaceutical Pricing Authority) raising demands in respect of various formulations. One such demand notice is dated 02.07.2015 and is in connection with the scheduled formulation - 'Acivir 200 DT Tablet'. For the sake of convenience, the said demand notice is reproduced herein below:-

"F.No. 25(11)2013/Div.IV(OC-II)/NPPA National Pharmaceutical Pricing Authority Department of Pharmaceuticals Ministry of Chemicals & Fertilizers Government of India 5th /3rd Floor, YMCA Cultural Centre Building, No.1, Jai Singh Road, New Delhi-110 001 Date: 02.07.2015 To M/s Cipla Limited M/s Cipla Limited Mumbai Central, Kumrek, Rangpo, Mumbai - 400 008, Sikkim-737 132, (MAHARASHTRA) (SIKKIM) DEMAND NOTICE Sub: DPCO, 2013: Manufacturing/marketing of scheduled formulation 'Acivir 200 DT Tablet' at a price higher than notified price- reg.

2. Due to non-receipt of the quantitative details from the company, a Show Cause Notice was issued on 21.04.2015 based on Pharmatrac data from the period June, 2013.to February, 2015. However, NPPA has not received any response from the company after the issue of reminder till date. The said formulation was available in the market on 09th August 2013, well after the expiry of 45 days from the date of notification of the ceiling price notified by the Govt./NPPA.

5. Based on the available information, the overcharged amount was estimated at Rs 1,09,74,235/- (Rupees One Crore Nine Lakh Seventy Four Thousand Two Hundred And Thirty Five Only) for the period from June, 2013 to March, 2015 and the same is required to be deposited with the Government of India. In addition, the company is also liable to pay interest @15% on overcharged amount which amounts to Rs 21,99,307/- upto 20.07.2015.

6. Thus, the company is liable to deposit the total amount of Rs. 1,31,73,541/- (Rupees One Crore Thirty One Lakh Seventy Three Thousand Five Hundred And Forty One Only) consisting of overcharged amount along with interest thereon calculated upto 20.07.2015 as per Annexure-I by way of demand draft drawn in favour of "The Pay and Account Officer (NPPA), Deptt. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, New Delhi"